# Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine

> **NCT01224613** · PHASE4 · COMPLETED · sponsor: **Dalhousie University** · enrollment: 276 (estimated)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Intanza
- **BIOLOGICAL:** Intanza

## Key facts

- **NCT ID:** NCT01224613
- **Lead sponsor:** Dalhousie University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-01
- **Final completion:** 2011-02
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2011-06-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01224613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01224613, "Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01224613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
